Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep 28;14(10):433-42.
doi: 10.1186/2047-783x-14-10-433.

Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension

Lori Sweeney  1 , Norbert F Voelkel
Affiliations

Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension

Lori Sweeney et al. Eur J Med Res. .

Abstract

Severe pulmonary hypertension is a lethal group of disorders which preferentially afflicts women. It appears that in recent years the patient profile has shifted towards older, obese, and postmenopausal women, suggesting that endocrine factors may be important. Several studies have revealed an increased prevalence of thyroid disease in these patients, but no studies have evaluated for a coexistence of endocrine factors. In particular, no studies have attempted to evaluate for concurrent thyroid disease, obesity and long-term estrogen exposure in patients. 88 patients attending the Pulmonary Hypertension Association 8th International meeting completed a questionnaire and were interviewed. Information was collected regarding reproductive history, height, weight, and previous diagnosis of thyroid disease. 46% met criteria for obesity. 41% reported a diagnosis of thyroid disease. 81% of women reported prior use of hormone therapy. 70% reported greater than 10 years of exogenous hormone use. 74% of female patients reported two or more of potentially disease modifying endocrine factors (obesity, thyroid disease or estrogen therapy). The coexistent high prevalence in our cohort of exogenous estrogen exposure, thyroid disease and obesity suggests that an interaction of multiple endocrine factors might contribute to the pathogenesis of pulmonary hypertension and may represent epigenetic modifiers in genetically-susceptible individuals.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Reproductive risk factor point distribution for the cohort is shown according to menopause status.
Figure 2
Figure 2
Distribution of these risk factors and the combination of risk factors.
Figure 3
Figure 3
Schematic illustrating the potential interactions of pathobiologically relevant risk factos which may contribute to severe angioproliferative pulmonary arterial hypertension. Hypothetically, autoimmunity and chronic inflammation interact via thyroid disease, estrogen and obesity. VEGF = vascular endothelial growth factor, Bcl-2 = antiapoptotic B-cell lymphoma protein.
See this image and copyright information in PMC

References

    1. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G. et al.Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):5S–12S. - PubMed
    1. Voelkel NF, Reeves JT. Primary Pulmonary Hypertension in Pulmonary Vascular Diseases. New York: Marcel Dekker; 1979. Lung Biology in Health and Disease; pp. 573–628.
    1. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM. et al.Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987;107(2):216–23. - PubMed
    1. Hill NS, Preston IR, Roberts KE. Patients with Pulmonary Arterial Hypertension in Clinical Trials. Who Are They? Proc Am Thorac Soci. 2008;5:603–9. doi: 10.1513/pats.200803-032SK. - DOI - PubMed
    1. Badesch DB, Benza RL, Krichman AM, Raskob GE, Giles S. Reveal registry: baseline characteristics of the first 1,226 enrolled patients. Chest Meeting Abstracts. 2007;132(4):473b–474.

Publication types